Status:
COMPLETED
Post Cond No Reflow
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Myocardial Reperfusion Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
After having shown that postconditioning allowed a significant 36% reduction of infarct size as assessed by blood levels of myocardial enzymes in acute myocardial patients, the investigators objective...
Eligibility Criteria
Inclusion
- Patients \> 18 years old,
- Male or female,
- Presenting first myocardial infarction, with the beginning of pains \< 12 hours,
- Requiring a revascularisation by primary angioplasty or " rescue " (after failure of thrombolysis) on IVA or RCA (not CA).
- Artery guilty with TIMI flow = 0
Exclusion
- cardiac arrest before the angioplasty,
- Cardiogenic shock
- Occlusion of the artery circumflex responsible for the infarction
- Magnetic resonance imaging: contre indication
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01208727
Start Date
April 1 2009
End Date
March 1 2011
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Lyon, France